Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 411

Similar articles for PubMed (Select 17628212)

1.

Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia.

Scoto GM, Aricò G, Ronsisvalle S, Parenti C.

Peptides. 2007 Jul;28(7):1441-6. Epub 2007 Jun 14.

PMID:
17628212
2.
3.
4.

[Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray.

Chiou LC, Liao YY, Guerrini R, Calo' G.

Eur J Pharmacol. 2005 May 16;515(1-3):47-53.

PMID:
15896734
5.

Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.

Kuo CJ, Liao YY, Guerrini R, Calo' G, Chiou LC.

Eur J Pharmacol. 2008 Jan 28;579(1-3):110-5. Epub 2007 Oct 11.

PMID:
17976580
6.

Involvement of the Nociceptin/Orphanin FQ-NOP receptor system in the ventrolateral periaqueductal gray following mechanical allodynia in chronic pain.

Scoto GM, Aricò G, Iemolo A, Ronsisvalle S, Parenti C.

Life Sci. 2009 Jul 31;85(5-6):206-10. doi: 10.1016/j.lfs.2009.05.021. Epub 2009 Jun 11.

PMID:
19523963
8.

Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.

Chiou LC, Fan SH, Chuang KC, Liao YY, Lee SZ.

Ann N Y Acad Sci. 2004 Oct;1025:398-403. Review.

PMID:
15542742
9.
10.

Selective inhibition of the NOP receptor in the ventrolateral periaqueductal gray attenuates the development and the expression of tolerance to morphine-induced antinociception in rats.

Scoto GM, Aricò G, Iemolo A, Ronsisvalle G, Parenti C.

Peptides. 2010 Apr;31(4):696-700. doi: 10.1016/j.peptides.2009.12.028. Epub 2010 Jan 11.

PMID:
20067813
12.

Nociceptin/Orphanin FQ in PAG modulates the release of amino acids, serotonin and norepinephrine in the rostral ventromedial medulla and spinal cord in rats.

Lü N, Han M, Yang ZL, Wang YQ, Wu GC, Zhang YQ.

Pain. 2010 Mar;148(3):414-25. doi: 10.1016/j.pain.2009.11.025. Epub 2009 Dec 24.

PMID:
20036056
13.

Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.

Liao YY, Lee CW, Ho IK, Chiou LC.

Life Sci. 2012 Feb 13;90(7-8):306-12. doi: 10.1016/j.lfs.2011.12.004. Epub 2011 Dec 22.

PMID:
22213115
14.

[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.

Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.

Br J Pharmacol. 2002 May;136(2):303-11.

16.

Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.

Ozsoy HZ, Thakker DR, Standifer KM.

Mol Pharmacol. 2005 Aug;68(2):447-56. Epub 2005 May 12.

17.
18.

Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.

Marti M, Mela F, Veronesi C, Guerrini R, Salvadori S, Federici M, Mercuri NB, Rizzi A, Franchi G, Beani L, Bianchi C, Morari M.

J Neurosci. 2004 Jul 28;24(30):6659-66.

19.

Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices.

Liao YY, Teng SF, Lin LC, Kolczewski S, Prinssen EP, Lee LJ, Ho IK, Chiou LC.

Int J Neuropsychopharmacol. 2011 Aug;14(7):977-89. doi: 10.1017/S146114571000129X. Epub 2010 Oct 29.

PMID:
21029514
20.

UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.

Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, Regoli D.

CNS Drug Rev. 2005 Summer;11(2):97-112. Review.

PMID:
16007234
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk